<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366402">
  <stage>Registered</stage>
  <submitdate>23/05/2014</submitdate>
  <approvaldate>30/05/2014</approvaldate>
  <actrnumber>ACTRN12614000584639</actrnumber>
  <trial_identification>
    <studytitle>21-SMI-2014 A Post Market Observational Study on the Effect of Dorsal Root Ganglion (DRG) Stimulation in Patients with Chronic Low Back Pain Following Surgical Lumbar Discectomy (Failed Back Surgery Syndrome)</studytitle>
    <scientifictitle>A Post Market Observational Study on the Effect of DRG Stimulation in Patients with Chronic Low Back Pain Following Surgical Lumbar Discectomy (Failed Back Surgery Syndrome): SYMPATHY Study</scientifictitle>
    <utrn>U1111-1157-2704</utrn>
    <trialacronym>SYMPATHY</trialacronym>
    <secondaryid>21-SMI-2014</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Chronic low back pain following surgical lumbar discectomy (Failed Back Surgery Syndrome)</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Observational study on the effectiveness of DRG Stimulation. DRG stimulation is a type of Spinal Cord Stimulation (SCS) which targets specific neural structures with electrical therapy by implanting a stimulating electrode in the epidural space. Suitable subjects will first have a trial of the therapy to determine effect and if successful will have the full system implanted. Implanted subjects will be followed prospectively for 1 year with follow up observations at 1 week, 1 month, 3 month, 6 month and 12 months post implant.</interventions>
    <comparator>NA</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Pain Relief using a 100mm Visual Analogue Scale (VAS)</outcome>
      <timepoint>12 Months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Safety - Continual monitoring for device related (Serious) Adverse Events (S)AE's
Possible Adverse Events related to the therapy will be have been fully explained to potential subjects by the primary investigator as part of their pre-treatment screening and evaluation</outcome>
      <timepoint>12 Months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of Life - EQ-5D</outcome>
      <timepoint>12 Months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Subject Satisfaction - 7 Point Likert Scale</outcome>
      <timepoint>12 Months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Physical Function - Brief Pain Inventory (BPI) and Oswestry Disability Index (ODI)</outcome>
      <timepoint>12 Months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Chronic Low Back Pain following surgical lumbar discectomy</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Surgical spinal procedures other than a lumbar discectomy
Significant bi-lateral leg pain greater in intensity than their low back pain</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>30/06/2014</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Spinal Modulation Inc</primarysponsorname>
    <primarysponsoraddress>1135 O'Brien Drive
Menlo Park - 94025
CA
USA</primarysponsoraddress>
    <primarysponsorcountry>United States of America</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Spinal Modulation Pty Ltd</fundingname>
      <fundingaddress>Level 31 120 Collins Street,
Melbourne
VIC
3000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>An observational, questionnaire based study in which the effectiveness of DRG stimulation as a treatment for chronic low back pain will be assessed in patients routinely scheduled for this treatment</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Bellberry Ltd</ethicname>
      <ethicaddress>129 Glen Osmond Road
Eastwood 
South Australia 5063</ethicaddress>
      <ethicapprovaldate />
      <hrec>2014-05-270</hrec>
      <ethicsubmitdate>22/05/2014</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Marc Russo</name>
      <address>Australian Pain Research Centre T/A Hunter Clinical Research
220 Denison Street
Broadmeadow
NSW - 2292</address>
      <phone>+61 2 4985 1848</phone>
      <fax />
      <email>admin@hunterclinicalresearch.com.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Tiana Laurie</name>
      <address>Australian Pain Research Centre T/A Hunter Clinical Research
220 Denison Street
Broadmeadow
NSW - 2292</address>
      <phone>+61 2 4985 1848</phone>
      <fax />
      <email>admin@hunterclinicalresearch.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Marc Russo</name>
      <address>Australian Pain Research Centre T/A Hunter Clinical Research
220 Denison Street
Broadmeadow
NSW - 2292</address>
      <phone>+61 2 4985 1848</phone>
      <fax />
      <email>admin@hunterclinicalresearch.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>